title: Gratifying clinical experience with an indigenously formulated single-vial lyophilized HYNIC-TOC kit at the radiopharmaceutical division of BARC: a pivotal boost for building up a peptide receptor radionuclide therapy programme in an Indian setting.
authors.affiliation: Radiation Medicine Centre (B.A.R.C), Tata Memorial Centre Annexe, Jerbai Wadia Road, Parel, Mumbai, 400012, India, drsanb@yahoo.com.
authors.forename: Sandip
authors.initials: S
authors.lastname: Basu
authors.forename: Purushottam
authors.initials: P
authors.lastname: Kand
authors.forename: Madhav
authors.initials: M
authors.lastname: Mallia
authors.forename: Aruna
authors.initials: A
authors.lastname: Korde
authors.forename: Hemant
authors.initials: H
authors.lastname: Shimpi
mesh_terms: D006801:Humans; D007194:India; D015282:Octreotide / Q000031:analogs & derivatives* / Q000191:economics / Q000600:supply & distribution / Q000627:therapeutic use; D015609:Organotechnetium Compounds / Q000191:economics / Q000600:supply & distribution / Q000627:therapeutic use*; D019275:Radiopharmaceuticals / Q000191:economics / Q000600:supply & distribution / Q000627:therapeutic use*; D011933:Reagent Kits, Diagnostic; D015899:Tomography, Emission-Computed, Single-Photon
chemical_list: D015609:Organotechnetium Compounds; D019275:Radiopharmaceuticals; D011933:Reagent Kits, Diagnostic; C410263:technetium Tc 99m hydrazinonicotinyl-Tyr(3)-octreotide; D015282:Octreotide